HomeLXEO • NASDAQ
add
Lexeo Therapeutics Inc
Previous close
$2.55
Day range
$2.19 - $2.62
Year range
$1.45 - $19.50
Market cap
75.03M USD
Avg Volume
1.07M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.02M | 33.29% |
Net income | -25.92M | -82.73% |
Net profit margin | — | — |
Earnings per share | -0.78 | — |
EBITDA | -27.23M | -83.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 121.52M | 0.04% |
Total assets | 146.94M | 5.10% |
Total liabilities | 30.10M | 14.57% |
Total equity | 116.84M | — |
Shares outstanding | 33.20M | — |
Price to book | 0.72 | — |
Return on assets | -42.68% | — |
Return on capital | -49.52% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -25.92M | -82.73% |
Cash from operations | -28.33M | -102.60% |
Cash from investing | -93.58M | -128,095.89% |
Cash from financing | -97.00K | -100.10% |
Net change in cash | -122.01M | -241.84% |
Free cash flow | -19.22M | -108.22% |
About
Founded
2017
Website
Employees
72
